Sean Dodge
Stock Analyst at RBC Capital
(1.98)
# 3,070
Out of 4,948 analysts
133
Total ratings
31.58%
Success rate
-3.77%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $2.92 | +105.48% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $1.11 | +215.32% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $191.09 | +41.29% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.52 | +59.57% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $175.99 | +49.44% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $9.30 | +82.80% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $28.70 | +11.50% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $16.86 | -64.41% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $89.89 | +16.81% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $15.74 | +8.01% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $36.08 | -5.76% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $19.28 | -27.39% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $3.73 | +168.10% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.27 | +31.64% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $15.02 | -6.79% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $177.99 | -81.46% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $0.33 | +54,461.99% | 2 | Mar 9, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $2.92
Upside: +105.48%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $1.11
Upside: +215.32%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $191.09
Upside: +41.29%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.52
Upside: +59.57%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $175.99
Upside: +49.44%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.30
Upside: +82.80%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $28.70
Upside: +11.50%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $16.86
Upside: -64.41%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $89.89
Upside: +16.81%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $15.74
Upside: +8.01%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $36.08
Upside: -5.76%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $19.28
Upside: -27.39%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $3.73
Upside: +168.10%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $21.27
Upside: +31.64%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $15.02
Upside: -6.79%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $177.99
Upside: -81.46%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $0.33
Upside: +54,461.99%